Part of the Will Luigi Mangione be convicted of criminal charges? topic →
This market asks whether Mangione will avoid any criminal conviction in both the federal and New York state cases by January 1, 2027. The federal guilty plea to two stalking charges is already reported as entered and operative, and the topic rules count a guilty plea as a conviction without requiring sentencing. A successful reversal before the deadline is the key exception, but the reviewed reporting does not indicate that the plea has been withdrawn or set aside; the state case’s unresolved status does not change that federal plea. External sentiment offered no directly matching No Charges probability.
Released transcripts show plea discussions had taken place before Mangione entered his federal guilty plea on August 14.
Mangione’s federal guilty plea to two stalking-resulting-in-death charges blocks the No Charges outcome under the topic rules unless overturned before the resolution date; sentencing is scheduled for December 18, 2026, with no reversal reported.
Mangione admitted in court to shooting and killing UnitedHealthcare CEO Brian Thompson, marking a dramatic guilty plea in the federal case.
Judge Gregory Carro ordered an anonymous jury on August 11, 2026, citing realistic and substantial risk of harassment, intimidation, or improper influence on prospective and sworn jurors.
Judge Gregory Carro confirmed jury selection will begin September 8, 2026 for the state murder trial in Manhattan. The trial is expected to last 6-8 weeks.
